The board of directors of Bristol-Myers Squibb Company (NYSE:BMY), a biopharmaceutical company, declared on Thursday its up sized quarterly dividend of USD0.41 per share (USD1.64 per share annually) on the USD0.10 par value common stock for the first quarter of 2019.
This 2.5% higher quarterly dividend is due on 1 February 2019 to common stockholders of record at the close of business as of 4 January 2019.
Additionally, the company's board approved its a quarterly dividend of USD0.50 per share on the USD2.00 convertible preferred stock.
Stockholders of record at the close of business as of 5 February 2019 will receive the preferred stock dividend on 1 March 2019.
Danaher Corporation announces quarterly cash dividend
Abbott announces quarterly common dividend
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva